Next-generation Biopharmaceutical Downstream Process

This site describes Horizon 2020 funded project entitled Next-generation biopharmaceutical downstream process, which is carried out by consortium of seven partners.

Learn more


Project Info

Implementation of a fully integrated manufacturing platform for biosimilar mAb based on continuous chromatography, in combination with single-use disposable technology for all unit operations of DSP on pilot/small production scale together with incorporation of advanced analytical tools.